GoodRx taps former McKesson exec to lead corporate strategy

Press enter to search
Close search
Open Menu

GoodRx taps former McKesson exec to lead corporate strategy

By Sandra Levy - 06/17/2020

GoodRx, America’s healthcare marketplace, has a new leader. The company has named Bansi Nagji as president of health care. Nagji has more than 25 years of experience in health care, growth management and corporate M&A. The company said that he will drive corporate strategy and build industry relationships to bolster the expansion of GoodRx’s services.

Nagji joins GoodRx from McKesson, where he served as executive vice president and chief strategy and business development officer, overseeing a period of rapid expansion of their strategic capabilities via acquisitions and industry partnerships.

Prior to McKesson, Bansi was a principal of Deloitte Consulting, where he led their global strategy practice. He had previously served as president of Monitor Group, a global strategy consulting firm, and was instrumental in the integration of Monitor into Deloitte’s operations. Nagji has previously served on a number of boards, including that of Change Healthcare. 

“GoodRx’s singular purpose to help Americans and its big ambitions to improve healthcare make this a very exciting company,” Nagji said. “I look forward to helping the business scale at a time when affordable healthcare is so critical.”

Additionally, GoodRx has named Karsten Voermann as CFO. With over 20 years of experience, Voermann will help scale GoodRx’s financial operations, including resource allocation and implementation of key financial systems.

“Americans need affordable healthcare now more than ever. We’ve already helped Americans save over $20 billion and we’re committed to reaching even more people during this critical time by offering new services and partnerships,” said GoodRx co-CEO and co-founder Doug Hirsch. “As we embark on our next stage of growth, Bansi will be crucial in leading our strategy and expanding our footprint across healthcare while Karsten will be fundamental in scaling GoodRx’s financial operations.”

Related Topics